ArticleJournal of thoracic disease2024

The efficacy of neoadjuvant immune checkpoint inhibitors in lung squamous cell carcinoma and adenocarcinoma: a systematic review and single-arm meta-analysis.

Junguo Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.